Omega Diagnostics Group (ODX)
ODX Share PerformanceMore
|52 week high||26.62 25/05/17|
|52 week low||15.00 13/02/18|
|52 week change||-1.63 (-9.45%)|
|4 week volume||1,369,153 27/01/18|
Media for (ODX)
Latest News« previous» nextMore
12/01/2018 - 12:14 RNS
RNS Number: 7661B Omega Diagnostics Group PLC 12 January 2018 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Omega...
21/12/2017 - 08:09 StockMarketWire
Omega, the medical diagnostics company, has CE-Marked an additional eight allergens to extend its menu to 49 allergens. T...
21/12/2017 - 07:00 RNS
RNS Number: 9977Z Omega Diagnostics Group PLC 21 December 2017 Omega Diagnostics Group PLC ("Omega" or the "Company") Allersys CE-Mark Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has CE-Marked an additional eight allergens to extend its menu to 49 allergens. Ome...
14/12/2017 - 09:30 StockMarketWire
finnCap today reaffirms its corporate investment rating on Omega Diagnostics Group PLC (LON:ODX) and cut its price t...
14/12/2017 - 09:22 StockMarketWire
Omega Diagnostics' Andrew Shepherd has agreed to step down as chief executive officer and from the board with immed...
14/12/2017 - 09:03 StockMarketWire
Omega Diagnostics, the medical diagnostics, increased its revenue by 4% to 7.11m in the six months ended 30 September. Foo...
14/12/2017 - 07:01 RNS
RNS Number: 3006Z Omega Diagnostics Group PLC 14 December 2017 Omega Diagnostics Group PLC ("Omega" or the "Company") CEO succession Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that as part of Omega's Board succession planning, Andrew Shepherd has agreed to step down...
14/12/2017 - 07:00 RNS
RNS Number: 3004Z Omega Diagnostics Group PLC 14 December 2017 OMEGA DIAGNOSTICS GROUP PLC ("Omega" or the "Company" or the "Group") INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2017 Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces its un...
|Dividend yield||0 %|
Latest discussion posts More
“This was lifted from ADVFN board. Whoever compiled this deserves our gratitude. Your efforts are appreciated. Significant shareholders: 05 September 2017 Richard ...”▼
“Good to see the price ticking up well yesterday, and today's additional tick up on a 32k buy is hopefully more evidence that any overhang has now cleared.”▼
“Bought some more today.”▼
Codes & Symbols
|Symbols||ODX, LSE:ODX, ODX.L, ODX:LN, LON:ODX, XLON:ODX|
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment